SEP 20, 2020 3:30 PM PDT

New Drug Shows Promise in Treating Advanced COVID-19

WRITTEN BY: Annie Lennon

As the COVID-19 pandemic rages on, the search for drugs to combat the virus is ongoing. Now, scientists have found that a new drug, known as 4-Phenulbutiric acid (4-PBA), can modulate the body's inflammatory response to COVID-19 in animals. 

In the study, the authors note that the inflammatory process common in patients with severe cases of COVID-19 causes the release of cytokines- immune cells that then put the body's immune system into overdrive in what's known as a cytokine storm. Leading blood vessels to become extremely permeable, it often results in multiple organ failure and then death. As such, treating these cytokine storms is essential for managing the disease. 

Already, 4-PBA, under the name 'Buphenyl', is used as an anti-stress drug against other diseases that modulate cellular stress, including urea cycle disorders. As such, the researchers set out to see whether the drug could also be used to combat similar stress caused by COVID-19. 

From animal tests, the researchers confirmed that the treatment was able to 'fully curb mortality caused by respoirtory failure from cellular stress'. 

The researchers also managed to identify the endoplasmic reticulum resistant protein, 'Binding Immunoglobulin Protein' (BiP), a biomarker for cellular stress in the blood. They managed to do so by finding a correlation between high levels of the biomarker and inflammatory severity from COVID-19 infections. 

As such, the researchers say that BiP levels could both serve as an early indicator for how effective 4-BPA treatment may be, as well as to indicate groups at more risk of severe complications from COVID-19. 

"Therefore, if we know that the patient suffers from cellular stress, we can kill two birds with one stone - we can detect susceptibility before infection occurs and know how to treat it in due time," says co-author of the study, Ivan Duran, from the University of Malaga in Spain. 

 

Sources: Deccan HeraldFDA

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 08, 2020
Space & Astronomy
New Drug May Allow Astronauts to Spend Years in Space
SEP 08, 2020
New Drug May Allow Astronauts to Spend Years in Space
Without gravity from Earth, muscles and bones tend to weaken quickly. To combat this, astronauts usually need to spend t ...
SEP 03, 2020
Drug Discovery & Development
Combination of Cholesterol Lowering Drugs Effective in Reducing Heart Disease
SEP 03, 2020
Combination of Cholesterol Lowering Drugs Effective in Reducing Heart Disease
A recent European study found that individuals taking a combination of lipid-lowering therapeutics may reduce the risk o ...
SEP 15, 2020
Drug Discovery & Development
How Can Genetic Data Make Informed Decisions About Drug Development?
SEP 15, 2020
How Can Genetic Data Make Informed Decisions About Drug Development?
How Can Genetic Data Make Informed Decisions About Drug Development? Scientists at the Integrative Epidemiology Unit (MR ...
OCT 12, 2020
Microbiology
Researchers May Have Found a Way to Cure Rotavirus Infections
OCT 12, 2020
Researchers May Have Found a Way to Cure Rotavirus Infections
Rotaviruses are very contagious. They are the most common cause of diarrhea in children and are estimated to cause about ...
OCT 12, 2020
Cannabis Sciences
Can Cannabis Relieve Symptoms of Down Syndrome?
OCT 12, 2020
Can Cannabis Relieve Symptoms of Down Syndrome?
Increasing anecdotal and academic evidence has been emerging in recent years about the plethora of health benefits behin ...
OCT 20, 2020
Drug Discovery & Development
New Treatment Reverses Late Stage Type 2 Diabetes
OCT 20, 2020
New Treatment Reverses Late Stage Type 2 Diabetes
Researchers from the Netherlands have developed a minimally invasive therapeutic procedure that allows people to discont ...
Loading Comments...